Drug-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
In: bioRxiv, 2020.02.13.947374, 41 S.
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2020
- Urheber
-
Michaelis, Martin
Wass, Mark N.
Reddin, Ian
Voges, Yvonne
Rothweiler, Florian
Hehlgans, Stephanie
Cinatl, Jaroslav
Mernberger, Marco
Nist, Andrea
Stiewe, Thorsten
Rödel, Franz
Cinatl, Jindrich
- DOI
-
10.1101/2020.02.13.947374
- URN
-
urn:nbn:de:hebis:30:3-726911
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Michaelis, Martin
- Wass, Mark N.
- Reddin, Ian
- Voges, Yvonne
- Rothweiler, Florian
- Hehlgans, Stephanie
- Cinatl, Jaroslav
- Mernberger, Marco
- Nist, Andrea
- Stiewe, Thorsten
- Rödel, Franz
- Cinatl, Jindrich
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2020
Ähnliche Objekte (12)
YM155-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
![Suppression von TNFα [TNFalpha] durch Yersinia Outer Protein B : ein neuer Pathogenitätsmechanismus in der akuten Yersiniose](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Suppression von TNFα [TNFalpha] durch Yersinia Outer Protein B : ein neuer Pathogenitätsmechanismus in der akuten Yersiniose
Drug-resistant cell lines in cancer
Brief von Franz Rödel an Otto von Taube, 18.10.1948
Drug-resistant urothelial cancer cell lines display diverse sensitivity profiles to potential second-line therapeutics
Intact-cell maldi-tof mass spectrometry for the authentication of drug-adapted cancer cell lines
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Überwindung der ABC-Transporter-vermittelten Chemoresistenz in Neuroblastomzellen
YM155-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
Suppression von TNFα [TNFalpha] durch Yersinia Outer Protein B : ein neuer Pathogenitätsmechanismus in der akuten Yersiniose
Drug-resistant cell lines in cancer
Brief von Franz Rödel an Otto von Taube, 18.10.1948
Drug-resistant urothelial cancer cell lines display diverse sensitivity profiles to potential second-line therapeutics
Intact-cell maldi-tof mass spectrometry for the authentication of drug-adapted cancer cell lines
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Überwindung der ABC-Transporter-vermittelten Chemoresistenz in Neuroblastomzellen
YM155-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
Suppression von TNFα [TNFalpha] durch Yersinia Outer Protein B : ein neuer Pathogenitätsmechanismus in der akuten Yersiniose
Drug-resistant cell lines in cancer
Brief von Franz Rödel an Otto von Taube, 18.10.1948
Drug-resistant urothelial cancer cell lines display diverse sensitivity profiles to potential second-line therapeutics
Intact-cell maldi-tof mass spectrometry for the authentication of drug-adapted cancer cell lines
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells